Miransertib
Miransertib (ARQ-092) is a potent, selective, and orally available allosteric inhibitor of Akt. It is widely used in preclinical research to investigate oncogenic PI3K/Akt pathway signaling, demonstrating activity in both in vitro cellular assays and in vivo xenograft models for cancers and overgrowth syndromes.
Product Specifications
CAS Number
1313881-70-7
Product Name Alternative
AKT inhibitor 2, Akt1, AKT1-E17K, Akt2, Akt3, Akt, anti-tumor, anti-proliferative, ARQ092, ARQ-092, ARQ 092, Inhibitor, inhibit, Miransertib, Parasite, p-Akt, p-PRAS40, Protein kinase B, PKB
Field of Research
Infectious Disease & Virology, Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.31 mM) ; DMSO:12.75 mg/mL (29.48 mM)
Smiles
Nc1ncccc1-c1nc2ccc (nc2n1-c1ccc (cc1) C1 (N) CCC1) -c1ccccc1
Molecular Formula
C27H24N6
Molecular Weight
432.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV740558 1.0 µg DNA
PIRC38 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details 
AP20636PU-N 100 µg
beta Sarcoglycan (SGCB) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 